M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026
M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026
M&A / Deals Argenx deepens immuno expertise with $2.2B Forte Biosciences buy pharminent July 27, 2026
M&A / Deals Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics pharminent July 20, 2026
M&A / Deals Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover pharminent July 16, 2026
M&A / Deals AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B pharminent July 14, 2026
M&A / Deals Novartis and Chai Discovery collaborate on antibody identification pharminent July 14, 2026
M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026
M&A / Deals AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical pharminent July 8, 2026
M&A / Deals Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant pharminent July 8, 2026
M&A / Deals Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal pharminent July 1, 2026
M&A / Deals Ionis grants Recordati rights to zilganersen for Alexander disease pharminent June 26, 2026
M&A / Deals URA and Lilly join forces to harmonise drug-wearable obesity care pharminent June 24, 2026
M&A / Deals LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs pharminent June 18, 2026
